Novolog
NDC Package 68258-8899-3
Package Information
Novolog is insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Marketed by Dispensing Solutions, Inc., this product is identified by NDC 68258-8899 and is authorized under FDA application NDA020986.
Identification & Billing
- RxCUI: 1653202 - insulin aspart 100 UNT/ML in 3 ML Pen Injector
- RxCUI: 1653202 - 3 ML insulin aspart, human 100 UNT/ML Pen Injector
- RxCUI: 1653202 - insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector
- RxCUI: 1653204 - NovoLOG 100 UNT/ML in 3 ML Pen Injector
- RxCUI: 1653204 - 3 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLog]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68258 - Dispensing Solutions, Inc.
- 68258-8899 - Novolog
- 68258-8899-3 - 3 mL in 1 SYRINGE, PLASTIC
- 68258-8899 - Novolog
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68258-8899-3 identifies a specific commercial package of 3 ml in 1 syringe, plastic of Novolog, labeled by Dispensing Solutions, Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 3 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dispensing Solutions, Inc. on January 22, 2003. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.
How is this Dispensing Solutions, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68258889903. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 3 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.
